Sagent Pharmaceuticals Enters Ophthalmic Market, Launches Travoprost Ophthalmic Solution
Travoprost is the first ophthalmic product offering in Sagent's portfolio, with plans to launch more products in the coming year.
Ocular Hypertension | 16/09/2025 | By Dineshwori
Akums Becomes First Indian CDMO to Receive DCGI Approval for Innovative Glaucoma Treatment
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide, with India contributing to 23.5 percent of the global burden.
Ocular Hypertension | 01/04/2025 | By Abha | 285
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy